Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains-Reference-Cited by-同舟云学术

Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains

Published:2017-09-18 Issue:3 Volume:32 Page:729-735
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Sidana S,Tandon N,Dispenzieri A,Gertz M A,Buadi F K,Lacy M Q,Dingli D,Fonder A L,Hayman S R,Hobbs M A,Gonsalves W I,Hwa Y L,Kapoor P,Kyle R A,Leung N^ORCID,Go R S,Lust J A,Russell S J,Zeldenrust S R,Rajkumar S V,Kumar S K

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2017286.pdf

Reference26 articles.

1. Merlini G, Seldin DC, Gertz MA . Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol 2011; 29: 1924–1933.

2. Gertz MA . Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment. Am J Hematol 2016; 91: 947–956.

3. Mollee P, Merlini G . Free light chain testing for the diagnosis, monitoring and prognostication of AL amyloidosis. Clin Chem Lab Med 2016; 54: 921–927.

4. Abraham RS, Katzmann JA, Clark RJ, Bradwell AR, Kyle RA, Gertz MA . Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis. Am J Clin Pathol 2003; 119: 274–278.

5. Bochtler T, Hegenbart U, Heiss C, Benner A, Cremer F, Volkmann M et al. Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis. Haematologica 2008; 93: 459–462.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical trials landscape in immunoglobulin light chain amyloidosis: a systematic review;Blood Advances;2024-06-28

2. Systemic Amyloidosis and Kidney Transplantation: An Update;Seminars in Nephrology;2024-01

3. Prognostic Value of Holter Monitoring in Light Chain Amyloidosis;Journal of Clinical Medicine;2023-12-01

4. Early cardiac response is possible in stage IIIb cardiac AL amyloidosis and is associated with prolonged survival;Blood;2022-11-03

5. Pathologic light chain amyloidosis oligomer detection in urinary extracellular vesicles as a diagnostic tool for response and progression of disease;Frontiers in Oncology;2022-10-04